AAAAAA

   
Results: 1-25 | 26-27
Results: 1-25/27
ANTITUMOR NECROSIS FACTOR-ALPHA MONOCLONAL-ANTIBODY THERAPY FOR RHEUMATOID-ARTHRITIS
Authors: KAVANAUGH AF
Citation: Af. Kavanaugh, ANTITUMOR NECROSIS FACTOR-ALPHA MONOCLONAL-ANTIBODY THERAPY FOR RHEUMATOID-ARTHRITIS, Rheumatic diseases clinics of North America, 24(3), 1998, pp. 593
THE VARIABLE IMPACT OF SOCIAL SUPPORT ACCORDING TO RACE, ECONOMIC-STATUS AND DISEASE-ACTIVITY IN PATIENTS WITH SLE
Authors: BAE SC KARLSON EW HASHIMOTO H ROBERTS WN KAVANAUGH AF STERN SH STRAATON KV LIANG MH DALTROY LH
Citation: Sc. Bae et al., THE VARIABLE IMPACT OF SOCIAL SUPPORT ACCORDING TO RACE, ECONOMIC-STATUS AND DISEASE-ACTIVITY IN PATIENTS WITH SLE, Arthritis and rheumatism, 41(9), 1998, pp. 1534-1534
REPEAT TREATMENT OF RHEUMATOID-ARTHRITIS PATIENTS WITH A MURINE ANTI-INTERCELLULAR ADHESION MOLECULE-1 MONOCLONAL-ANTIBODY
Authors: KAVANAUGH AF SCHULZEKOOPS H DAVIS LS LIPSKY PE
Citation: Af. Kavanaugh et al., REPEAT TREATMENT OF RHEUMATOID-ARTHRITIS PATIENTS WITH A MURINE ANTI-INTERCELLULAR ADHESION MOLECULE-1 MONOCLONAL-ANTIBODY, Arthritis and rheumatism, 40(5), 1997, pp. 849-853
ELEVATED CYTOKINE MESSENGER-RNA LEVELS IN THE PERIPHERAL-BLOOD OF PATIENTS WITH RHEUMATOID-ARTHRITIS SUGGEST DIFFERENT DEGREES OF MYELOID CELL ACTIVATION
Authors: SCHULZEKOOPS H DAVIS LS KAVANAUGH AF LIPSKY PE
Citation: H. Schulzekoops et al., ELEVATED CYTOKINE MESSENGER-RNA LEVELS IN THE PERIPHERAL-BLOOD OF PATIENTS WITH RHEUMATOID-ARTHRITIS SUGGEST DIFFERENT DEGREES OF MYELOID CELL ACTIVATION, Arthritis and rheumatism, 40(4), 1997, pp. 639-647
RISK-FACTORS FOR EARLY WORK DISABILITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS - RESULTS FROM A MULTICENTER STUDY
Authors: PARTRIDGE AJ KARLSON EW DALTROY LH LEW RA WRIGHT EA FOSSEL AH STRAATON KV STERN SH KAVANAUGH AF ROBERTS WN LIANG MH
Citation: Aj. Partridge et al., RISK-FACTORS FOR EARLY WORK DISABILITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS - RESULTS FROM A MULTICENTER STUDY, Arthritis and rheumatism, 40(12), 1997, pp. 2199-2206
THE RELATIONSHIP OF SOCIOECONOMIC-STATUS, RACE, AND MODIFIABLE RISK-FACTORS TO OUTCOMES IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
Authors: KARLSON EW DALTROY LH LEW RA WRIGHT EA PARTRIDGE AJ FOSSEL AH ROBERTS WN STERN SH STRAATON KV WACHOLTZ MC KAVANAUGH AF GROSFLAM JM LIANG MH
Citation: Ew. Karlson et al., THE RELATIONSHIP OF SOCIOECONOMIC-STATUS, RACE, AND MODIFIABLE RISK-FACTORS TO OUTCOMES IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS, Arthritis and rheumatism, 40(1), 1997, pp. 47-56
AN EVIDENCE-BASED MEDICINE APPROACH TO THE DIAGNOSIS AND MANAGEMENT OF MUSCULOSKELETAL COMPLAINTS
Authors: ELLRODT AG CHO M CUSH JJ KAVANAUGH AF LIPSKY PE
Citation: Ag. Ellrodt et al., AN EVIDENCE-BASED MEDICINE APPROACH TO THE DIAGNOSIS AND MANAGEMENT OF MUSCULOSKELETAL COMPLAINTS, The American journal of medicine, 103, 1997, pp. 3-6
RHEUMATOID-ARTHRITIS IN THE ELDERLY - IS IT A DIFFERENT DISEASE
Authors: KAVANAUGH AF
Citation: Af. Kavanaugh, RHEUMATOID-ARTHRITIS IN THE ELDERLY - IS IT A DIFFERENT DISEASE, The American journal of medicine, 103, 1997, pp. 40-48
A PHASE I II OPEN-LABEL STUDY OF THE SAFETY AND EFFICACY OF AN ANTI-ICAM-1 (INTERCELLULAR-ADHESION MOLECULE-1 - CD54) MONOCLONAL-ANTIBODY IN EARLY RHEUMATOID-ARTHRITIS/
Authors: KAVANAUGH AF DAVIS LS JAIN RI NICHOLS LA NORRIS SH LIPSKY PE
Citation: Af. Kavanaugh et al., A PHASE I II OPEN-LABEL STUDY OF THE SAFETY AND EFFICACY OF AN ANTI-ICAM-1 (INTERCELLULAR-ADHESION MOLECULE-1 - CD54) MONOCLONAL-ANTIBODY IN EARLY RHEUMATOID-ARTHRITIS/, Journal of rheumatology, 23(8), 1996, pp. 1338-1344
PERSISTENT REDUCTION IN IL-6 MESSENGER-RNA IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS OF PATIENTS WITH RHEUMATOID-ARTHRITIS AFTER TREATMENT WITHA MONOCLONAL-ANTIBODY TO CD54 (ICAM-1)
Authors: SCHULZEKOOPS H LIPSKY PE KAVANAUGH AF DAVIS LS
Citation: H. Schulzekoops et al., PERSISTENT REDUCTION IN IL-6 MESSENGER-RNA IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS OF PATIENTS WITH RHEUMATOID-ARTHRITIS AFTER TREATMENT WITHA MONOCLONAL-ANTIBODY TO CD54 (ICAM-1), Clinical and experimental immunology, 106(2), 1996, pp. 190-196
ANTI-TNF-ALPHA MONOCLONAL-ANTIBODY (MAB) TREATMENT OF RHEUMATOID-ARTHRITIS (RA) PATIENTS WITH ACTIVE DISEASE ON METHOTREXATE (MTX) - RESULTS OF A DOUBLE-BLIND, PLACEBO-CONTROLLED MULTICENTER TRIAL
Authors: KAVANAUGH AF CUSH JJ STCLAIR EW MCCUNE WJ BRAAKMAN TAJ NICHOLS LA LINSKY PE
Citation: Af. Kavanaugh et al., ANTI-TNF-ALPHA MONOCLONAL-ANTIBODY (MAB) TREATMENT OF RHEUMATOID-ARTHRITIS (RA) PATIENTS WITH ACTIVE DISEASE ON METHOTREXATE (MTX) - RESULTS OF A DOUBLE-BLIND, PLACEBO-CONTROLLED MULTICENTER TRIAL, Arthritis and rheumatism, 39(9), 1996, pp. 575-575
THE GENERATION OF ALGORITHMS FOR THE DIAGNOSIS AND MANAGEMENT OF MUSCULOSKELETAL (MS) COMPLAINTS - RESULTS OF A NATIONAL MULTIDISCIPLINARY EFFORT
Authors: CUSH JJ KAVANAUGH AF LIPSKY PE
Citation: Jj. Cush et al., THE GENERATION OF ALGORITHMS FOR THE DIAGNOSIS AND MANAGEMENT OF MUSCULOSKELETAL (MS) COMPLAINTS - RESULTS OF A NATIONAL MULTIDISCIPLINARY EFFORT, Arthritis and rheumatism, 39(9), 1996, pp. 820-820
1995 NATIONAL SURVEY OF US RHEUMATOLOGISTS - BELIEFS AND PRACTICES REGARDING THERAPY, REFERRALS, MANAGED CARE, GUIDELINES AND ALGORITHMS
Authors: CUSH JJ KAVANAUGH AF LIPSKY PE
Citation: Jj. Cush et al., 1995 NATIONAL SURVEY OF US RHEUMATOLOGISTS - BELIEFS AND PRACTICES REGARDING THERAPY, REFERRALS, MANAGED CARE, GUIDELINES AND ALGORITHMS, Arthritis and rheumatism, 39(9), 1996, pp. 821-821
ANTI-TNF-ALPHA MONOCLONAL-ANTIBODY (MAB) TREATMENT OF RHEUMATOID-ARTHRITIS (RA) PATIENTS WITH ACTIVE DISEASE ON METHOTREXATE (MTX) - RESULTS OF OPEN-LABEL, REPEATED DOSE ADMINISTRATION FOLLOWING A SINGLE-DOSE DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Authors: KAVANAUGH AF CUSH JJ CLAIR EWS MCCUNE WJ BRAAKMAN TAJ NICHOLS LA LIPSKY PE
Citation: Af. Kavanaugh et al., ANTI-TNF-ALPHA MONOCLONAL-ANTIBODY (MAB) TREATMENT OF RHEUMATOID-ARTHRITIS (RA) PATIENTS WITH ACTIVE DISEASE ON METHOTREXATE (MTX) - RESULTS OF OPEN-LABEL, REPEATED DOSE ADMINISTRATION FOLLOWING A SINGLE-DOSE DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, Arthritis and rheumatism, 39(9), 1996, pp. 1296-1296
FIBROMYALGIA OR MULTIORGAN DYSESTHESIA
Authors: KAVANAUGH AF
Citation: Af. Kavanaugh, FIBROMYALGIA OR MULTIORGAN DYSESTHESIA, Arthritis and rheumatism, 39(1), 1996, pp. 180-181
BIOLOGIC INTERVENTIONS IN RHEUMATOID-ARTHRITIS
Authors: CUSH JJ KAVANAUGH AF
Citation: Jj. Cush et Af. Kavanaugh, BIOLOGIC INTERVENTIONS IN RHEUMATOID-ARTHRITIS, Rheumatic diseases clinics of North America, 21(3), 1995, pp. 797-816
ELEVATED TH1- OR TH0-LIKE CYTOKINE MESSENGER-RNA IN PERIPHERAL-CIRCULATION OF PATIENTS WITH RHEUMATOID-ARTHRITIS - MODULATION BY TREATMENT WITH ANTI-ICAM-1 CORRELATES WITH CLINICAL BENEFIT
Authors: SCHULZEKOOPS H LIPSKY PE KAVANAUGH AF DAVIS LS
Citation: H. Schulzekoops et al., ELEVATED TH1- OR TH0-LIKE CYTOKINE MESSENGER-RNA IN PERIPHERAL-CIRCULATION OF PATIENTS WITH RHEUMATOID-ARTHRITIS - MODULATION BY TREATMENT WITH ANTI-ICAM-1 CORRELATES WITH CLINICAL BENEFIT, The Journal of immunology, 155(10), 1995, pp. 5029-5037
INDUCTION OF PERSISTENT T-CELL HYPORESPONSIVENESS IN-VIVO BY MONOCLONAL-ANTIBODY TO ICAM-1 IN PATIENTS WITH RHEUMATOID-ARTHRITIS
Authors: DAVIS LS KAVANAUGH AF NICHOLS LA LIPSKY PE
Citation: Ls. Davis et al., INDUCTION OF PERSISTENT T-CELL HYPORESPONSIVENESS IN-VIVO BY MONOCLONAL-ANTIBODY TO ICAM-1 IN PATIENTS WITH RHEUMATOID-ARTHRITIS, The Journal of immunology, 154(7), 1995, pp. 3525-3537
EVIDENCE OF EARLY ORGAN DAMAGE IN SLE
Authors: RIVEST C KARLSON EW PARTRIDGE AJ LEW RA WRIGHT EA DALTROY LH FOSSEL AH ROBERTS WH STERN SH STRAATON KV WACHOLTZ MC KAVANAUGH AF GROSFLAM JM LIANG MH
Citation: C. Rivest et al., EVIDENCE OF EARLY ORGAN DAMAGE IN SLE, Arthritis and rheumatism, 38(9), 1995, pp. 414-414
ELEVATED TH1-LIKE CYTOKINE MESSENGER-RNA IN THE PERIPHERAL-CIRCULATION OF PATIENTS WITH RHEUMATOID-ARTHRITIS - MODULATION BY TREATMENT WITHA MONOCLONAL-ANTIBODY TO ICAM-1
Authors: SCHULZEKOOPS H LIPSKY PE KAVANAUGH AF DAVIS LS
Citation: H. Schulzekoops et al., ELEVATED TH1-LIKE CYTOKINE MESSENGER-RNA IN THE PERIPHERAL-CIRCULATION OF PATIENTS WITH RHEUMATOID-ARTHRITIS - MODULATION BY TREATMENT WITHA MONOCLONAL-ANTIBODY TO ICAM-1, Arthritis and rheumatism, 38(9), 1995, pp. 825-825
IMMUNOLOGICAL ASPECTS OF RHEUMATIC DISEASES - IMPLICATIONS FOR TREATMENT
Authors: KAVANAUGH AF LIPSKY PE
Citation: Af. Kavanaugh et Pe. Lipsky, IMMUNOLOGICAL ASPECTS OF RHEUMATIC DISEASES - IMPLICATIONS FOR TREATMENT, CLINICAL IMMUNOTHERAPEUTICS, 1(3), 1994, pp. 209-216
TREATMENT OF RHEUMATOID-ARTHRITIS PATIENTS WITH A MONOCLONAL-ANTIBODYTO INTERCELLULAR-ADHESION MOLECULE-I (ICAM-1) RESULTS IN T-LYMPHOCYTEHYPORESPONSIVENESS TO IN-VITRO MITOGENIC STIMULATION
Authors: SCHULZEKOOPS H KAVANAUGH AF LIPSKY PE DAVIS LS
Citation: H. Schulzekoops et al., TREATMENT OF RHEUMATOID-ARTHRITIS PATIENTS WITH A MONOCLONAL-ANTIBODYTO INTERCELLULAR-ADHESION MOLECULE-I (ICAM-1) RESULTS IN T-LYMPHOCYTEHYPORESPONSIVENESS TO IN-VITRO MITOGENIC STIMULATION, The FASEB journal, 8(5), 1994, pp. 10000745-10000745
INHIBITION OF THE TRANSENDOTHELIAL MIGRATION OF HUMAN T-LYMPHOCYTES BY PROSTAGLANDIN E(2)
Authors: OPPENHEIMERMARKS N KAVANAUGH AF LIPSKY PE
Citation: N. Oppenheimermarks et al., INHIBITION OF THE TRANSENDOTHELIAL MIGRATION OF HUMAN T-LYMPHOCYTES BY PROSTAGLANDIN E(2), The Journal of immunology, 152(12), 1994, pp. 5703-5713
TREATMENT OF REFRACTORY RHEUMATOID-ARTHRITIS WITH A MONOCLONAL-ANTIBODY TO INTERCELLULAR-ADHESION MOLECULE-1
Authors: KAVANAUGH AF DAVIS LS NICHOLS LA NORRIS SH ROTHLEIN R SCHARSCHMIDT LA LIPSKY PE
Citation: Af. Kavanaugh et al., TREATMENT OF REFRACTORY RHEUMATOID-ARTHRITIS WITH A MONOCLONAL-ANTIBODY TO INTERCELLULAR-ADHESION MOLECULE-1, Arthritis and rheumatism, 37(7), 1994, pp. 992-999
MASSIVE EOSINOPHILIC SYNOVITIS AND REACTIVE ARTHRITIS-ASSOCIATED WITHFILARIAL INFECTION
Authors: KOHEM CL KRISTIANSEN SV KAVANAUGH AF
Citation: Cl. Kohem et al., MASSIVE EOSINOPHILIC SYNOVITIS AND REACTIVE ARTHRITIS-ASSOCIATED WITHFILARIAL INFECTION, Annals of the Rheumatic Diseases, 53(4), 1994, pp. 281-282
Risultati: 1-25 | 26-27